Clinical Trial Update: Safety Evaluation of the KLOX BioPhotonic System in Diabetic Foot Ulcers [NA]

View source ↗

Summary

The update reports a completed safety evaluation trial of the KLOX BioPhotonic System in diabetic foot ulcers (NCT02222506) sponsored by KLOX Technologies Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Foot Ulcers

Drugs mentioned

• KLOX Biophotonic System

Snippet

Sponsor: KLOX Technologies Inc. | Conditions: Diabetic Foot Ulcers | NA | Status: COMPLETED